CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Gregory L. Hall, MD
As every healthcare professional knows, the best drug is the one the patient will take. So, how do you improve your patient’s compliance and adherence to a treatment regimen? As Dr. Hall will discuss, the key to success is understanding your patient’s “world-view” and how they think about medicine and why many may prefer alternative medicine. He’ll share with you his secret sauce for engaging and motivating patients: clinical storytelling. He’ll even share the five ingredients that make that story convincing and behavior changing.
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
Improving the Management of Patients with IPF Through Disease, Symptom, and Support-Centered Management
Erica Herzog, MD, PhD | Amy Olson, MD, MSPH
During this podcast, expert pulmonologists who specialize in the field of interstitial lung disease (ILD) focus on how to manage the care of patients with IPF through disease, symptom and support-centered strategies with an emphasis on how all of these components and various healthcare specialties work together to help the patient in their journey.
For more interstitial lung disease (ILD) educational content, please visit www.InsightsinILD.com
Vice Chief for Basic and Translational Research, Pulmonary, Critical Care & Sleep Medicine, Director, Yale Interstitial Lung Disease (ILD) Center of Excellence, Pulmonary, Critical Care & Sleep Medicine, Associate Dean, Medical Student Research, Yale School of Medicine
Assistant Professor, Department of Medicine, Medical Director, Pulmonary Physiology Unit, National Jewish Health
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.